FTD has for example been shown to exert at least part of its antitumor effect by activation of the p53 pathway, resulting in p21 induction and cell cycle arrest31, a mechanism recapitulated by scRNA-seq (Fig. 3C). The gene discussed is CDKN1A; the disease is frontotemporal dementia.